|
|
| Unaudited Quarterly Results for the Quarter & Half year ended 30th September, 2007 |
|
| |
Stand alone |
Consolidated |
| |
Three months ended |
Six months ended |
Year Ended |
Three months ended |
Six months ended |
Year Ended |
| Particulars |
30.09.2007 |
30.09.2006 |
30.09.2007 |
30.09.2006 |
31.03.2007 |
30.09.2007 |
30.09.2007 |
31.03.2007 |
| |
Unaudited |
Unaudited |
Unaudited |
Unaudited |
Audited |
Unaudited |
Unaudited |
Audited |
| Sales/Income from Operations(including excise duty) |
6,408.10 |
4,800.00 |
11,494.90 |
9,185.60 |
19,797.20 |
6,669.60 |
12,334.00 |
22,502.20 |
| Less: Excise Duty |
292.1 |
261.7 |
579.4 |
505.8 |
1,011.50 |
385.8 |
726.8 |
1,273.00 |
| Net Sales/Income from Operations |
6,116.00 |
4,538.30 |
10,915.50 |
8,679.80 |
18,785.70 |
6,283.80 |
11,607.20 |
21,229.20 |
| Other Income |
376 |
134.7 |
705.6 |
158.8 |
431.3 |
270 |
605.3 |
496.3 |
| Total Income |
6,492.00 |
4,673.00 |
11,621.10 |
8,838.60 |
19,217.00 |
6,553.80 |
12,212.50 |
21,725.50 |
| Expenditure |
|
|
|
|
|
|
|
|
| a. (Increase)/Decrease in Stock |
(236.2) |
84.4 |
(581.5) |
(360.7) |
(744.2) |
(327.4) |
(766.9) |
(890.5) |
| b. Material Consumed |
3,785.70 |
2,513.40 |
7,025.90 |
5,412.50 |
11,923.70 |
3,309.30 |
6,346.20 |
11,755.80 |
| c. Purchase of traded goods |
63.4 |
28.3 |
108.3 |
50.4 |
480.7 |
452.6 |
782.8 |
1,351.00 |
| d. Staff Cost |
382.9 |
288.1 |
719.5 |
546.1 |
1,128.80 |
492.9 |
935.1 |
1,504.20 |
| e. Depreciation/Amortisation |
188.2 |
149.9 |
361.9 |
292.7 |
718.4 |
249.5 |
483 |
997.1 |
| f. Other Expenditure |
1,042.40 |
933.2 |
2,026.40 |
1,681.80 |
3,210.70 |
1,422.60 |
2,681.30 |
4,490.00 |
| Total Expenditure |
5,226.40 |
3,997.30 |
9,660.50 |
7,622.80 |
16,718.10 |
5,599.50 |
10,461.50 |
19,207.60 |
| Profit before interest & tax |
1,265.60 |
675.7 |
1,960.60 |
1,215.80 |
2,498.90 |
954.3 |
1,751.00 |
2,517.90 |
| Interest (net) |
40.7 |
70.1 |
85.1 |
104 |
187.3 |
116.1 |
222.4 |
453.6 |
| Profit from Ordinary Activities before tax |
1,224.90 |
605.6 |
1,875.50 |
1,111.80 |
2,311.60 |
838.2 |
1,528.60 |
2,064.30 |
| Provision for Taxation |
|
|
|
|
|
|
|
|
| a. Current Tax |
199.9 |
60.5 |
275.6 |
118.6 |
180.5 |
199.1 |
279.8 |
203.4 |
| b. MAT Credit Entitlement |
3.8 |
(13.7) |
- |
(65.9) |
(145.4) |
3.9 |
- |
(145.4) |
| c. Deferred Tax |
10.7 |
11.5 |
3 |
148.9 |
(40.6) |
10.7 |
3 |
(40.6) |
| d. Fringe Benefit Tax |
1.3 |
0.9 |
2.3 |
1.7 |
3.9 |
1.3 |
2.3 |
3.9 |
| e. Tax adjustments of previous years |
- |
- |
- |
- |
22.4 |
- |
- |
22.4 |
| Total Tax |
215.7 |
59.2 |
280.9 |
203.3 |
20.8 |
215 |
285.1 |
43.7 |
| Profit before Minority Interest |
1,009.20 |
546.4 |
1,594.60 |
908.5 |
2,290.80 |
623.2 |
1,243.50 |
2,020.60 |
| Minority Interest |
|
|
|
|
|
(26) |
(56) |
(110) |
| Net Profit for the period |
1,009.20 |
546.4 |
1,594.60 |
908.5 |
2,290.80 |
597.2 |
1,187.50 |
1,910.60 |
| Paid-up Equity Share Capital |
2,686.97 |
2,664.70 |
2,686.97 |
2,664.70 |
2,667.43 |
|
|
2,667.43 |
| (Face value Rs. 5 per share) |
|
|
|
|
|
|
|
|
| Reserves excluding Revaluation Reserve |
|
|
|
|
90,206 |
|
|
85,875 |
| Basic Earnings per share before & after Extraordinary items (Rs.) (not annualised) |
18.8 |
10.25 |
29.79 |
17.05 |
42.98 |
11.56 |
23.13 |
37.7 |
| Diluted Earnings per share before & after Extraordinary items (Rs.) (not annualised) |
14.94 |
7.99 |
23.66 |
13.8 |
34.51 |
9.19 |
18.37 |
30.27 |
| Aggregate of non-promoters Shareholding |
|
|
|
|
|
|
|
|
| a. Number of Shares |
|
|
24,024,339 |
23,751,179 |
23,636,405 |
|
|
|
| b. Percentage of Shareholding |
|
|
44.71 |
44.57 |
44.31 |
|
|
|
|
|
|
| Notes: |
| 1. |
The above unaudited results were reviewed by the Audit Committee and have been approved by the Board at its meeting held on 31.10.2007.
The quarterly stand alone results are subject to Limited Review by Auditors of the Company. |
| 2. |
The Consolidated Quarterly Results, which are optional, have been presented for the first time by the Company during the year, so as to provide additional information; and consequently no comparative figures of corresponding quarter of previous year is given. |
| 3. |
The consolidated Quarterly Results have been prepared in accordance with AS - 21 on 'Consolidated Financial Statement', AS-27 'Financial Reporting of Interests in Joint Ventures' and includes Quarterly Results of all subsidiaries and 50:50 Joint Ventures. |
| 4. |
The Company's operations fall within a single primary business segment viz. 'Pharmaceutical Products'. |
| 5. |
Investor complaints pending at the beginning of the quarter: Nil, received: 35, resolved: 35 and lying unresolved at the end of the quarter Nil. |
| 6. |
Sales for the quarter include exports of Rs. 4053.4 millions (Rs.2801.7 millions). |
| 7. |
The Committee of Board of Directors of the Company on 11th July, 2007 has considered the request and allotted 3,74,046 Equity Shares of Rs. 5 each for cash at a premium of Rs. 517.036 by conversion of Foreign Currency Convertible Bonds worth USD 4.5 Million (out of USD 60 Million) in terms of the offer document to the FCCB holders. Further, the Compensation Committee of the Company at their meeting held on 31st July, 2007 allotted 16,638 Equity Shares of Rs. 5 each at a premium of Rs.357.60 per share under ESOP 2004 Scheme. Consequently, the paid-up share capital of the Company has increased to Rs. 268.7 millions. |
| 8. |
Premium on redemption of USD 255.5 Million zero coupon Foreign Currency Convertible Bonds is contingent in nature, the outcome of which is dependant on uncertain future events. |
| 9. |
During the quarter, the Company has formed new subsidiaries viz., APL Holdings (Jersey) Ltd. & APL IP Company Ltd. in Jersey; and Agile Malta Holdings Ltd. & Aurobindo Pharma (Malta) Ltd. in Malta. The Equity investment in Aurobindo TongLing (Datong) Pharmaceutical Company Limited, China disinvested pending share transfer formalities. |
| 10. |
Figures for the previous periods have been rearranged/regrouped wherever necessary. |
|
|
|
|
By Order of the Board |
| Place: Hyderabad |
|
K.Nityananda Reddy |
| Date : 31.10.2007 |
|
Managing Director |
|
|
|
